Insider · CIK 0001185040

BINGHAM KATE

Reports to the SEC for 1 company · CAMBRIDGE, X0

sec.gov

Transactions

Companies

Filings

CIK

0001185040

Forms 4 and 5

Insider transactions

20 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-07-14	BCYCBICYCLE THERAPEUTICS PLCS Sale	Director	SSale	−43.4K sh	$34.01	−$1.48M	1,831,671
2021-07-14	BCYCBICYCLE THERAPEUTICS PLCS Sale	Director	SSale	−43.4K sh	$34.01	−$1.48M	1,831,671
2021-07-14	BCYCBICYCLE THERAPEUTICS PLCS Sale	Director	SSale	−917 sh	$34.01	−$31.2K	38,708
2021-07-14	BCYCBICYCLE THERAPEUTICS PLCS Sale	Director	SSale	−917 sh	$34.01	−$31.2K	38,708
2021-07-13	BCYCBICYCLE THERAPEUTICS PLCS Sale	Director	SSale	−588 sh	$33.50	−$19.7K	1,875,049
2021-07-13	BCYCBICYCLE THERAPEUTICS PLCS Sale	Director	SSale	−12 sh	$33.50	−$402	39,625
2021-07-13	BCYCBICYCLE THERAPEUTICS PLCS Sale	Director	SSale	−588 sh	$33.50	−$19.7K	1,875,049
2021-07-13	BCYCBICYCLE THERAPEUTICS PLCS Sale	Director	SSale	−12 sh	$33.50	−$402	39,625
2021-01-04	BCYCBICYCLE THERAPEUTICS PLC · Stock Option (right to buy)A Award	Director	AAward	+19K sh	—	—	19,000
2020-01-02	BCYCBICYCLE THERAPEUTICS PLC · Stock Option (right to buy)A Award	Director	AAward	+16K sh	—	—	16,000
2019-05-28	BCYCBICYCLE THERAPEUTICS PLC · Series B1 Preferred SharesC Conversion	Director	CConversion	−13.2K sh	—	—	0
2019-05-28	BCYCBICYCLE THERAPEUTICS PLCC Conversion	Director	CConversion	+875K sh	—	—	874,709
2019-05-28	BCYCBICYCLE THERAPEUTICS PLCC Conversion	Director	CConversion	+623K sh	—	—	1,497,905
2019-05-28	BCYCBICYCLE THERAPEUTICS PLCC Conversion	Director	CConversion	+18.5K sh	—	—	18,485
2019-05-28	BCYCBICYCLE THERAPEUTICS PLCC Conversion	Director	CConversion	+13.2K sh	—	—	31,654
2019-05-28	BCYCBICYCLE THERAPEUTICS PLCP Purchase	Director	PPurchase	+378K sh	$14.00	+$5.29M	1,875,637
2019-05-28	BCYCBICYCLE THERAPEUTICS PLCP Purchase	Director	PPurchase	+7,983 sh	$14.00	+$112K	39,637
2019-05-28	BCYCBICYCLE THERAPEUTICS PLC · Series A Preferred SharesC Conversion	Director	CConversion	−875K sh	—	—	0
2019-05-28	BCYCBICYCLE THERAPEUTICS PLC · Series B1 Preferred SharesC Conversion	Director	CConversion	−623K sh	—	—	0
2019-05-28	BCYCBICYCLE THERAPEUTICS PLC · Series A Preferred SharesC Conversion	Director	CConversion	−18.5K sh	—	—	0

Recent filings

Accepted (ET)
Jul 204/A
BINGHAM KATE0000899243-21-028984
SEC(opens sec.gov)
Jul 154
BINGHAM KATE0000899243-21-028546
SEC(opens sec.gov)
Jan 54
BINGHAM KATE0001209191-21-001321
SEC(opens sec.gov)
Jan 64
BINGHAM KATE0001209191-20-001917
SEC(opens sec.gov)
May 304
BINGHAM KATE0001104659-19-032915
SEC(opens sec.gov)

Companies

BICYCLE THERAPEUTICS PLCDirectorBCYC

Address

C/O BICYCLE THERAPEUTICS PLC B900, BABRAHAM RESEARCH CAMPUS

CAMBRIDGE, X0, CB22 3AT